Over the past 30 years, progress in early detection and treatment of cancer has helped reduce the overall death rate by more than 30%. Pancreatic cancer, however, has remained difficult to treat. Only 1 in 9 people survive five years after diagnosis, in part because this cancer is protected by biological factors that help it resist treatment.
Click here for original story, ‘Glass bubble’ nanocarrier boosts effects of combination therapy for pancreatic cancer
Source: Phys.org